Breast Implant Safety: an Overview of Current Regulations and Screening Guidelines.
Where this comes from
- Record sourced from PubMed, PMID 34027608.
- Also identified by DOI 10.1007/s11606-021-06899-y and PMC identifier 8738800.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Breast implant surgery for cosmetic or reconstructive purposes is becoming increasingly common. While the devices used are regulated and approved by the US Food and Drug Administration, all patients with breast implants require continued follow-up. Many patients will seek this care from their primary care providers, especially when follow-up with their plastic surgeon is difficult. It is vital that treating clinicians are knowledgeable about the history of breast implants, routine screening guidelines, and the recent breast implant "hot topics"-breast implant-associated anaplastic large cell lymphoma (BIA-ALCL), connective tissue disease, and breast implant illness. This paper will provide the necessary information for primary care providers to appropriately counsel patients with breast implants to maintain not only their trust, but also their health.
Medical subject headings
- Breast Implantation
- Breast Implants
- Breast Neoplasms
- Lymphoma, Large-Cell, Anaplastic